All Press Releases for May 12, 2020

Thomas R. Bailey, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Thomas R. Bailey, PhD, has been endorsed by Marquis Who's Who as a leader in the field of chemistry



Dr. Thomas R. Bailey co-invented over 50 U.S. patents.

    PHOENIXVILLE, PA, May 12, 2020 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Thomas R. Bailey, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Bailey celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Having accrued more than 30 years of inimitable expertise within his field, Dr. Bailey has garnered a laudable reputation as the president of TR Bailey Consulting LLC in Phoenixville, having founded the consulting firm in 2012. A medicinal chemist who specializes in drug discovery, drug development and outsource management, his company serves small- to medium-sized businesses in the design and development of new drugs. Dr. Bailey's extensive experience has notably included working for such well-known organizations as Cephalon Inc., and ViroPharma Inc. as a senior scientist, and Sterling-Winthrop Inc. as a senior research chemist, senior research investigator and principal research investigator in New York and Pennsylvania.

As a seasoned researcher, Dr. Bailey co-invented over 50 U.S. patents. He notably co-invented Tecovirimat, a novel smallpox drug that was selected by U.S. government for the national bio-defense initiative. The drug was recently approved by the Federal Drug Administration in 2019. He also was an inventor on the antipicornaviral series of inhibitors that resulted in the NDA candidate pleconaril. Additionally, he has been an integral part of teams that delivered 7 clinical candidates. As a result of his many years of research, Dr. Bailey has authored and co-authored approximately 40 articles in various scholarly journals in his area of expertise and has served as a reviewer for the Journal of Medicinal Chemistry.

Dr. Bailey completed a Bachelor of Science in chemistry at The Ohio State University in 1978, during which time he published five professional works in peer reviewed journals. He subsequently completed a Doctor of Philosophy in synthetic organic chemistry at Pennsylvania State University in 1982 before spending another two years as a postdoctoral fellow studying organic synthesis under Dr. A.I. Meyers at Colorado State University in Fort Collins, Colorado. Since concluding his academic efforts, Dr. Bailey has maintained his professional alignment with the American Chemical Society and the New York Academy of Science.

About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
USA
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: